Baseline TMTV and Dmax prognostic value in patients with advanced melanoma treated with first-line immune checkpoint inhibitors

被引：0
|
作者：
Vercellino, L. [1 ]
Jallerat, P. [1 ]
Delyon, J. [1 ]
Martineau, A. [1 ]
Baroudjian, B. [1 ]
Poudroux, W. [1 ]
Lebbe, C. [1 ]
Merlet, P. [1 ]
机构：
[1] Hop St Louis, Paris, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-693
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [21] Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition
    Liang, Xiaocui
    Zhou, Shan
    Xiao, Zefeng
    AGING-US, 2023, 15 (17): : 8770 - 8781
  • [22] Prognostic value of baseline and dynamic change value of CTC in advanced NSCLC patients treated with immune checkpoint inhibitor-based therapy
    Gao, G.
    Li, J.
    Zhou, F.
    Li, W.
    Xiong, A.
    Chen, X.
    Ren, S.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S857 - S858
  • [23] COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma
    Arenbergerova, M.
    Gkalpakiotis, S.
    Arenberger, P.
    Fialova, A.
    Pasek, M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1782 - 1783
  • [24] A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
    van Not, Olivier J.
    Wind, Thijs T.
    Ismail, Rawa K.
    Bhattacharya, Arkajyoti
    Jalving, Mathilde
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Boers-Sonderen, Marye J.
    van den Eertwegh, Alfonsus J. M.
    de Groot, Jan Willem B.
    Haanen, John B.
    Kapiteijn, Ellen
    Bloem, Manja
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    Fehrmann, Rudolf S. N.
    Hospers, Geke A. P.
    CANCERS, 2023, 15 (11)
  • [25] Long term outcomes of patients with advanced/unresectable melanoma treated with immune checkpoint inhibitors
    Sonke, Eric
    Angeles, Arkhjamil
    Nguyen, Thao Phuong
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors
    Yu Aoki
    Akihito Kawazoe
    Yohei Kubota
    Keigo Chida
    Saori Mishima
    Daisuke Kotani
    Yoshiaki Nakamura
    Yasutoshi Kuboki
    Hideaki Bando
    Takashi Kojima
    Toshihiko Doi
    Takayuki Yoshino
    Takeshi Kuwata
    Kohei Shitara
    International Journal of Clinical Oncology, 2022, 27 : 1413 - 1420
  • [27] Prognostic Value of FDG-PET Metrics for Advanced NSCLC Patients Treated with First-line Immunotherapy
    Andraos, T. Y.
    Halmos, B.
    Cheng, H.
    Huntzinger, C.
    Ohri, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E116 - E117
  • [28] Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors
    Aoki, Yu
    Kawazoe, Akihito
    Kubota, Yohei
    Chida, Keigo
    Mishima, Saori
    Kotani, Daisuke
    Nakamura, Yoshiaki
    Kuboki, Yasutoshi
    Bando, Hideaki
    Kojima, Takashi
    Doi, Toshihiko
    Yoshino, Takayuki
    Kuwata, Takeshi
    Shitara, Kohei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (09) : 1413 - 1420
  • [29] The outcome of advanced and recurrent cervical cancer patients treated with first-line platinum and paclitaxel with or without indication for immune checkpoint inhibitors: the comparative study
    Feng, Lan
    Shi, Qun
    Wang, Shujuan
    Zhao, Ye
    Wu, Haiyan
    Wei, Lei
    Hao, Qing
    Cui, Zhaojun
    Wang, Lin
    Zhang, Jing
    Zhang, Dan
    Zhan, Xinxin
    Jiang, Jingwen
    BMC CANCER, 2024, 24 (01)
  • [30] First-line immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma with sarcomatoid features
    Fontes-Sousa, Mario
    Calvo, Emiliano
    CANCER TREATMENT REVIEWS, 2022, 105
12345